Skip to main content

Splose

Category: AI in Healthcare

An AI-driven practice management platform designed specifically for allied health and NDIS providers to automate administrative workflows, clinical documentation, and complex billing. Splose was founded in 2016. The company is led by Nicholas Sanderson. Based in Adelaide, Australia. Team size: 44. Total funding raised: $52.5M. Latest round: Series A (Feb 2025). Key investors include ["Spectrum Equity","EVP (Equity Venture Partners)"].

Founded
2016
Headquarters
Adelaide, Australia
Team size
44
Total funding
$52.5M

Value proposition

Reduces administrative burnout by automating clinical note-taking and NDIS compliance, allowing practitioners to focus more on patient care and less on manual data entry.

Products and solutions

["Splose AI (Automated clinical notes and transcription)","Smart Scheduling & Calendar Management","Automated NDIS Invoicing & Bulk Claiming","Client Portal & Online Bookings","Progress Tracking & Clinical Forms","Financial Reporting & Analytics Dashboards"]

Unique value

Deep vertical integration with the Australian NDIS (National Disability Insurance Scheme) combined with a proprietary AI suite that converts session audio into structured clinical records.

Target customer

Allied health professionals (physiotherapists, speech pathologists, occupational therapists), NDIS service providers, and multi-disciplinary healthcare clinics.

Industries served

["Healthcare (Allied Health)","Disability Services (NDIS)","Mental Health","SaaS / HealthTech"]

Technology advantage

Leverages advanced LLMs specifically tuned for healthcare terminology to reduce note-taking time by up to 80%, while maintaining a high-compliance architecture for sensitive health data.

How they differentiate

Splose differentiates through its 'AI-first' approach, specifically 'Splose AI' which automates clinical note-taking and transcription. It also offers deeper vertical integration for the Australian NDIS (National Disability Insurance Scheme) compared to generalist platforms.

Main competitors

["Cliniko","Halaxy","Power Diary"]

Key partnerships

["Spectrum Equity (Lead Investor & Strategic Partner)","EVP (Equity Venture Partners)","Xero & QuickBooks (Accounting Integrations)","Stripe (Payment Processing)","Tyro (Health Fund Claiming)"]

Notable customers

["NDIS Service Providers","Multi-disciplinary Allied Health Clinics","Speech Pathology & Occupational Therapy Groups"]

Major milestones

["Launched Splose AI suite for automated clinical documentation in 2024","Secured $5M in expansion capital led by EVP in May 2024","Raised $46M Series A led by Spectrum Equity in Feb 2025 to fuel UK and US expansion"]

Growth metrics

Serves over 20,000 healthcare professionals; reported 100%+ year-on-year growth leading into 2025.

Market positioning

High-growth HealthTech challenger positioned as a premium, automation-focused alternative to legacy practice management software.

Geographic focus

Australia (Core), United Kingdom (Expansion), New Zealand

Patents and IP

No registered patents disclosed; relies on proprietary software architecture and trade-secret AI prompt engineering/workflows.

About Nicholas Sanderson

Nicholas Sanderson founded Splose in 2016 while studying at the University of Adelaide. Before launching the startup, he worked as a checkout operator at Woolworths, an experience he often cites as foundational to his understanding of customer service and operational efficiency. He has successfully scaled Splose from a student project into a leading global practice management platform, recently securing a $46 million Series A round to expand into the UK and enhance AI capabilities.

Official website: